Antianginal Flashcards
Principles of treatment of CCS
Use of antiischemic or antianginal agents and prevention of adverse cardiovascular event
No donors
Glyceril trinitrate,isosorbide mononitrate
1st gen beta Andre preceptor antagonist
Propranalol
Non dihydropiridine calcium channel blockers
Verapamil, diltiazem
Late Na flow inhibitor
Ranolazine
Sinoatrial node inhibitor
Ivabradine
Hypolipidemic agents are
Atorvastatin,fenofibrate,ezetimibs,evolozumab
Drugs used for prevention of adverse cardiovascular event
Hypolipidemic agents,RAAS, antiplatelet,ACE inhibitor,ARB
Cause of angina
Disrupted balance of oxygen supply and consumption
To reduce angina
Reduce oxygen consumption or increase oxygen supply
Oxygen demand increases when
Increase in HR, Contractions,wall tension, Preload ,afterload
Decrease oxygen supply due to
Decreased vessel caliber,perfusion pressure and increased HR, ventricular wall tension
Oxygen consumption can be reduced through
Reduced preload, afterload and CMV
Increased oxygen supply can be done through
Coronary blood vessel dilation, negative chronotropy
Negative chronotropy gives
Prolonged diastolic filling,so more oxygen supply
Nitrates and dihydropiridine calcium channel blockers cause
Reflex tachycardia
NO donors cause
Venodilation, arterial dilation and coronary arterial dilation,so hypotensive and antianginal effect
Glyceril trinitrate,fast and short acting
1-3min start, duration 20-30min, sublingual,first pass effect, antianginal
Side effects of glyceril nitrate
Headache, hypotension,reflex tachycardia
ISMN,Long acting,6-8 hr
Prevention of angina attack, interactions with pde5inhibitors cause life threatening hypotensive reaction
Dihydropiridine drugs are
Vasoselective calcium channel blockers -vasodilation
Dihydropiridine drugs acts on peripheral arteries and
Coronary arteries,cause dilation and antianginal and hypotensive effect
Side effects of dihydropiridine calcium channel blockers
Headache,facial flushing, fatigue, peripheral edema, constipation
Vasospastic anginais same as
Princmetals angina
Clinical use of dihydropiridine drugs
Prevention or prophylaxis of angina attack and prevention of vasospastic angina attack
Non dihydropiridine calcium channel blockers are
Cardiodepressent and are non selective
Clinical use of both calcium rare same
Prevention of angina attack and vasospastic angina attack
Action of non dihydropiridine blockers
Reduce CMV, peripheral arterial dilation,coronary artery dilation,diastole prolongation and reduce AV conduction
CCB acts on
L type voltage dependent calcium ion channels
Undamaged endothelium releasing NO and PGI2
Inhibits platelets activation
CCB s are
Metabolic poison , because it increases dependence on carbohydrate metabolism than FFA
CcBs cause
Coronary and peripheral vasodilation, decrease heart contractility,,slowed AV nodal conduction and depressed SA node activity
Beta blockers and verapamil interactions cause
Bradyarrythmia and if used parentaral asystole
Inhibitors of cyp450
Macrolide antibiotics and grapefruit juice
CCB intoxication cause
Hypotension and bradycardia and prolonged PR i,nausea, vomiting, metabolic acidosis and hyperglycaemia
Dihydropiridine cause
Vasodilatory shock
Verapamil and diltiazem cause
Vasodilatory and cardiogenic shock+bradycardia
Bradycardia can be caused by
Sinus bradycardia, second or 3rd degree AV block or sinus arrest
CCB doesn’t affect
QRS duration
CCB toxicity can be treated by
Calcium chloride or calcium gluconate for cardiac contraction, insulin against hyperglycaemia, Epinephrine, dobutamine or isoproterenol against cardiogenic shock and phenylephrine and norepinephrine against vasodilatory shock
HIET
High dose insulin euglycemic therapy
BAB are
Cardiodepressent
BAB action
Reduce CMV, prolonged diastole, reduce AV conduction
Use of BAB
Prevention of angina attack
Side effects of BAB
Bradycardia,AV block, bronchospasm, cold extremities
NO modulators have reflex increase in
HR and contractility
End diastolic volume and ejection fractions increase for
BAB and CCB
Ivabradin
Inhibits na ion flow in 4th phase of AP in SA node
Action of ivabradin
Dose dependent decrease of HR, prolonged diastole
Use of ivabradin
In prevention or prophylaxis of stable angina attack
Side effects of ivabradin (SA node inhibitor
Photopsy(light phenomenon in the retina, bradycardia
Ranolazine
Cause late blockade of na channels
Ranolazine action
Indirectly reduces intracellular calcium ion concentration and therefore reduce myocardial diastolic tension,so decrease oxygen consumption,improves perfusion
Atorvastatin action
g co A reductase inhibition +pleiotropic effects (plaque stabilization,,blocks synthesis of mevalonic acid in the liver, increase LDL receptor in liver and decrease LDL in plasma
Atorvastatin
hMG co A reductase inhibition +pleiotropic effects (plaque stabilization,,blocks synthesis of mevalonic acid in the liver, increase LDL receptor in liver and decrease LDL in plasma
Atorvastatin uses
Dyslipidemia, prevention of cardiovascular events
Side effects of atorvastatin
Hepatic function impairment (hepatopathy )and myopathy
Fibric acid derivatives
Fenofibrate
PPAR alpha agonist
Fenofibrate
Action of Fenofibrate
Activation of PPAR alpha leads to LPL gene expression ,lead serum LPL activation,lead to lipolysis, decrease TG and increase LDL receptor in liver
Cholesterol absorption inhibitor
Ezetimibe
Ezetimibe Acton
Blocks transport protein NPC1L1 in enterocyte villi-decrease cholesterol absorption (doesn’t affect fat sol but,TG or bile acids)-decrease LDL
PCSK9 inhibitor
Evolozumab
Evolozumab action
Inhibition of LDL receptor degrading enzymes
Evolozumab action
Human IgG2 binds with PCS K9 affecting PCSK9 mediated degrading of LDL receptor in liver -decrease LDL naturally
PCSK9
Proprotein convertase subtilisin/kexin type 9
Vasospastic angina can be treated by
CCB and long acting organic nitrates
Treatment of structural microvascular angia
BAB,ACE,statins
Microvascular functional changes(vasospastic form treatment
Calcium CB,Long lasting organic nitrate